Androgenetic Alopecia Treatment Market, by Drug Type (Topical Agents, 5 AR Inhibitors, and Others), by Route of Administration (Oral and Topical), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pha

Androgenetic Alopecia Treatment Market, by Drug Type (Topical Agents, 5 AR Inhibitors, and Others), by Route of Administration (Oral and Topical), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Androgenetic alopecia, a slow progressive form of alopecia, begins after the onset of puberty. Pattern or androgenetic alopecia is a genetically predetermined disorder due to excessive response to androgens that affects up to 50% of males and females globally, according to the National Center for Biotechnology Information (NCBI). It is characterized by progressive loss of terminal hair of the scalp, in a characteristic distribution in both males and females. In males, hair loss is most prominent in the vertex and frontotemporal regions, while in women the frontal hairline is typically spared with diffuse apical hair loss noted as a wider anterior part of the hair.
Market Dynamics
Rising incidence of androgenetic alopecia is expected to drive the global androgenetic alopecia treatment market growth. According to the National Library of Medicine (NLM), a medical library which is part of the National Institutes of Health (NIH), androgenetic alopecia affects approximately 50 million men and 30 million women in the U.S.
However, availability of alternative treatments is expected to hinder the market growth. For instance, hair restoration surgery such as scalp reduction surgeries, which is not used frequently but efficacy of hair transplantation is based on the principle of donor dominance.
Key features of the study:
This report provides in-depth analysis of the global androgenetic alopecia treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global androgenetic alopecia treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy’s Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd. among others
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global androgenetic alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global androgenetic alopecia treatment market.
Detailed Segmentation:
Global Androgenetic Alopecia Treatment Market, By Drug Type:
Topical Agents
5 AR Inhibitors
Others
Global Androgenetic Alopecia Treatment Market, By Route of Administration:
Oral
Topical
Global Androgenetic Alopecia Treatment Market, By Gender:
Male
Female
Global Androgenetic Alopecia Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Androgenetic Alopecia Treatment Market, By Region:
North America
By Drug Type:
Topical Agents
5 AR Inhibitors
Others
By Route of Administration:
Oral
Topical
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Drug Type:
Topical Agents
5 AR Inhibitors
Corticosteroids
Others
By Route of Administration:
Oral
Topical
Injectable
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Type:
Topical Agents
5 AR Inhibitors
Corticosteroids
Others
By Route of Administration:
Oral
Topical
Injectable
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Type:
Topical Agents
5 AR Inhibitors
Corticosteroids
Others
By Route of Administration:
Oral
Topical
Injectable
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Type:
Topical Agents
5 AR Inhibitors
Corticosteroids
Others
By Route of Administration:
Oral
Topical
Injectable
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type:
Topical Agents
5 AR Inhibitors
Corticosteroids
Others
By Route of Administration:
Oral
Topical
Injectable
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Histogen Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Cipla Limited
Aclaris Therapeutics, Inc.
Merck & Co., Inc.
Daiichi-Sankyo Co., Ltd.
Johnson and Johnson Services, Inc.
Lexington International LLC
Vita-Cos-Med Klett-Loch GmbH
PureTech
Vitabiotics
Dr. Reddy’s Laboratories
Ranbaxy Laboratories Ltd
HCell Inc.
Follica, Inc.
“*” marked represents similar segmentation in other categories in the respective section.